Clara Lin
Impact in
-
- Autoimmune and Inflammatory Disorders Research
-
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Inflammasome and immune disorders 2
-
- Spondyloarthritis Studies and Treatments 2
- Co-authors
- Diana Milojevic (3 shared papers)Jesse Courtier (2 shared papers)John D. MacKenzie (2 shared papers)Csaba Galambos (4 shared papers)Lisa F. Imundo (1 shared paper)Amy Lowichik (1 shared paper)Stephen L. Guthery (1 shared paper)John F. Bohnsack (1 shared paper)
- Journals
- Pediatric Rheumatology (4 papers)Arthritis Care & Research (2 papers)JAMA Network Open (1 paper)Lara D. Veeken (1 paper)Arthritis & Rheumatology (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Clara Lin
13 papers receiving 187 citations
Peers
Comparison fields: 5 of 37
- Hematology 55
- Rheumatology 59
- Physiology 11
- Pharmacology 29
- Rehabilitation 10
Countries citing papers authored by Clara Lin
This map shows the geographic impact of Clara Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Lin more than expected).
Fields of papers citing papers by Clara Lin
This network shows the impact of papers produced by Clara Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Lin. The network helps show where Clara Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Clara Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 50 | |
| 2 | 2014 | 42 | |
| 3 | 2018 | 32 | |
| 4 | 2016 | 23 | |
| 5 | 2024 | 11 | |
| 6 | 2015 | 10 | |
| 7 | 2021 | 6 | |
| 8 | 2019 | 4 | |
| 9 | 2017 | 4 | |
| 10 | 2022 | 2 | |
| 11 | 2025 | 1 | |
| 12 | 2012 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2024 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2023 | 0 |
About Clara Lin
Clara Lin is a scholar working on Molecular Biology, Rheumatology, Hematology, Surgery and Pharmacology, having authored 17 papers that have together received 187 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (3 papers), Inflammasome and immune disorders (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Salivary Gland Disorders and Functions (1 paper), Vasculitis and related conditions (1 paper), Drug-Induced Adverse Reactions (1 paper), Autoimmune Bullous Skin Diseases (1 paper) and Ocular Diseases and Behçet’s Syndrome (1 paper). The work is most often cited by research in Hematology (55 citations), Rheumatology (59 citations), Physiology (11 citations), Pharmacology (29 citations) and Rehabilitation (10 citations). Clara Lin has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Diana Milojevic, Jesse Courtier, John D. MacKenzie, Csaba Galambos, Lisa F. Imundo, Amy Lowichik, Stephen L. Guthery, John F. Bohnsack, Daniel Olson and Samuel R. Dominguez. Their work appears in journals such as Pediatric Rheumatology, Arthritis Care & Research, JAMA Network Open, Lara D. Veeken and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.